We have two core PhD programmes - traditional and transdisciplinary. Our PhD students are registered with Imperial and are embedded in our dedicated research facility.

Scientists have successfully prolonged the lifespan of animals.

AMP-activated protein kinase (AMPK) is a key evolutionarily conserved sensor of energy homeostasis, which is implicated in metabolic health and disease, as well as in ageing. Here, we show that direc...

Public voting accounts for 20 percent of the final score.

Professor Wiebke Arlt, Director of the MRC Laboratory of Medical Sciences (LMS) and Professor of Transdisciplinary Medicine at Imperial College London, is co-founder of a new spinout company developin...

Chronic stress from people’s everyday lives may be causing lasting structural changes to the heart, harming health and reducing life expectancy, according to new research from the MRC Laboratory of Me...

Professor Wiebke Arlt, Director of the MRC Laboratory of Medical Sciences (LMS), is playing a key role in a major international programme funded by SPRIND to develop Impli’s continuous hormone monitor...

Structural view of the MCM2-7 helicase with Sld3, Sld7 and Cdc45 bound at the site where Cdc45 is delivered. Structure derived from cryogenic electron microscopy data. Noguchi et al., 2026.

Researchers at the MRC Laboratory of Medical Sciences (LMS), Imperial College London and their collaborators have uncovered a crucial mechanism that cells use to control when to start DNA copying. Thi...

Researchers from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London, in collaboration with centres in Europe and the USA, have uncovered new genes linked to autoimmune conditions...

Professor Wiebke Arlt, Director of the Medical Research Council Laboratory of Medical Sciences (MRC LMS), spoke at the opening of Pfizer's new London research centre, reflecting on decades of publicly...

Researchers at the MRC Laboratory of Medical Sciences (LMS), Imperial College London and UCL Genetics Institute have created a detailed map of cells within breast tumours and identified distinct neigh...

DNA replication begins when inactive helicases are switched on to unwind DNA. Here, the authors map this activation in yeast, revealing where DNA first melts and how helicase splitting, factor release...

Researchers at the MRC Laboratory of Medical Sciences (LMS) and collaborators have uncovered one of the earliest steps in DNA replication: the moment a cell first opens its DNA to begin making a copy ...

The National Research Organisations (NRO) Group officially launched this month. A first of its kind collective for the UK, the NRO brings together more than 40 of the UK's national science and researc...

We’re delighted to welcome Dr CK Wong, who joins the MRC Laboratory of Medical Sciences (LMS) this month as Head of the Endocrine Signalling in Inflammation Group. His research explores how gut hormon...

Myricx Bio, a cancer therapy spinout from Imperial’s Department of Chemistry that has collaborated with researchers at the MRC Laboratory of Medical Sciences (LMS) since 2020, has announced it has rea...

Our Graduate Programme develops fresh science graduates into highly sought after technicians.

Dr Lara Curran, a clinician scientist and cardiology trainee at the MRC Laboratory of Medical Sciences (LMS), has been awarded a Clinical Early Career Research Fellowship from the British Heart Founda...

New research tracks how cells prepare gene regulatory decisions that will define their fate during the earliest stages of human development. The study reconstructs a timeline of chromosome folding tha...

Investigator Scientist (Roving Researcher) (LMS 2369) Salary £42,159 – 44,801 plus London Allowance (£5,560) per annum | 2 years fixed term | Full time | Closing Date: 21 June

Imperial researchers working across infectious disease, genomics, neuroscience and cardiovascular medicine are among those recognised in this year&rs...

View all the current vacancies at the MRC Laboratory of Medical Sciences, including research, technician, and support roles and jobs.

Dr Melanie Chan, a Transition-to-Independence Fellow in the Chain Florey Programme at the MRC Laboratory of Medical Sciences (LMS), has been awarded a highly competitive five-year MRC Clinician Scient...

A new set of drugs exploit a recently-revealed weakness in ‘zombie-like’ – or senescent – cells that could lead to new treatments for cancer and age-associated diseases. The study from the MRC Laborat...

In a new study published in Genes & Development, researchers from the labs of Stefan Mundlos (Max Planck Institute for Molecular Genetics and Charité, Berlin) and Lila Allou (MRC Laboratory of Medical...

In a new study published in Genes & Development, research led by Dr Lila Allou at the MRC Laboratory of Medical Sciences (LMS) in London and Professor Stefan Mundlos at the Max Planck Institute for Mo...